Mirum Pharmaceuticals, Inc.
MIRMBiotechnology
$86.39+0.68%As of Oct 29vs prior close
- Market cap
- $5.6B
- P/E (TTM)
- –
- From 52W high
- −32.81%
- EPS (LTM)
- -$14.54
- Revenue (LTM)
- $618.1M
- Net margin
- -139.18%
- Dividend yield
- 0.00%
Nomior Score
51
Steady ProfileSpeculativeTop 48% of the scored universe
Growth67
Quality40
Value50
Momentum60
Resilience39
Growth
$618.1Mrevenue, LTM
YE20 $0LTM $618.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 24% of revenue, wider by 20 pts on a year.
Who owns it
2funds, 1 tracked portfolio